These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 17126759)

  • 1. Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderly.
    O'Connor CM; Arumugham P
    Clin Geriatr Med; 2007 Feb; 23(1):141-53. PubMed ID: 17126759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderly.
    O'Connor CM; Arumugham P
    Heart Fail Clin; 2007 Oct; 3(4):477-84. PubMed ID: 17905382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic heart failure treatment in the year 2006].
    De Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute decompensated heart failure: best evidence and current practice.
    Mehta R; Feldman D
    Minerva Cardioangiol; 2005 Dec; 53(6):537-47. PubMed ID: 16333237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in heart failure medications in patients hospitalised and discharged.
    Scherer M; Sobek C; Wetzel D; Koschack J; Kochen MM
    BMC Fam Pract; 2006 Nov; 7():69. PubMed ID: 17123439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of systolic heart failure in the elderly: an evidence-based review.
    Arif SA; Mergenhagen KA; Del Carpio RO; Ho C
    Ann Pharmacother; 2010 Oct; 44(10):1604-14. PubMed ID: 20841514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of heart failure with preserved systolic function.
    de Groote P; Herpin D; Diévart F; Hanon O; Trochu JN; Artigou JY; Galinier M; Habib G; Juillière Y; Neuder Y; Roudaut R; Komajda M
    Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of in-hospital initiation of evidence-based medical therapies for heart failure-a review.
    Fonarow GC; Gheorghiade M; Abraham WT
    Am J Cardiol; 2004 Nov; 94(9):1155-60. PubMed ID: 15518610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure: update on treatment and prognosis.
    Futterman LG; Lemberg L
    Am J Crit Care; 2001 Jul; 10(4):285-93. PubMed ID: 11432217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurohormonal factors in heart failure (and III)].
    Cosín Aguilar J; Cruz Fernández JM; de Teresa Galván E; Ferreira Montero IJ; López-Sendón J; Soler Soler J; Tamargo Menéndez J
    Rev Esp Cardiol; 1996 Jun; 49(6):405-22. PubMed ID: 8753906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohormonal antagonism in heart failure: what is the optimal strategy?
    Sackner-Bernstein JD; Hart D
    Mt Sinai J Med; 2004 Mar; 71(2):115-26. PubMed ID: 15029403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure: recent advances in prevention and treatment.
    Fonarow GC
    Rev Cardiovasc Med; 2000; 1(1):25-33, 54. PubMed ID: 12457149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
    Rapp JA; Gheorghiade M
    Cardiol Clin; 2008 Feb; 26(1):23-40, vi. PubMed ID: 18312903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacological treatment of heart failure: are we looking at the sunset of the neurohormonal hypothesis.
    Porcu M
    Ital Heart J; 2002 Jul; 3(7):437-8. PubMed ID: 12189976
    [No Abstract]   [Full Text] [Related]  

  • 17. Heart failure update: treatment of heart failure with a normal left ventricular ejection fraction in the elderly.
    Aronow WS
    Geriatrics; 2006 Aug; 61(8):16-20. PubMed ID: 16901193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An approach to heart failure and diabetes mellitus.
    Fonarow GC
    Am J Cardiol; 2005 Aug; 96(4A):47E-52E. PubMed ID: 16098844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs for left ventricular remodeling in heart failure.
    Frigerio M; Roubina E
    Am J Cardiol; 2005 Dec; 96(12A):10L-18L. PubMed ID: 16399088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the treatment of heart failure with a preserved ejection fraction.
    Das A; Abraham S; Deswal A
    Curr Opin Cardiol; 2008 May; 23(3):233-40. PubMed ID: 18382212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.